Literature DB >> 28206807

Accounting for the association between BPD features and chronic pain complaints in a pain patient sample: The role of emotion dysregulation factors.

Caleb J Reynolds1, Ryan W Carpenter2, Sarah L Tragesser1.   

Abstract

Although borderline personality disorder (BPD) features consistently show strong relations with chronic pain, the mechanisms underlying this association remain unclear. BPD is characterized by dysregulated emotion. Given previously observed relationships between emotion dysregulation and pain, we hypothesized that components of this dysregulation-elevated and labile negative affect and emotion sensitivity-would account for the relationship between BPD features and various pain complaints in a chronic pain patient sample. Specifically, we hypothesized that negative affect would indirectly predict pain through higher emotion sensitivity to pain, operationalized as pain anxiety sensitivity. To test these hypotheses, we administered a series of self-report measures to 147 patients at a chronic pain treatment facility. As expected, BPD features predicted pain severity (β = .19, p = .029), activity interference from pain (β = .22, p = .015), and affective interference from pain (β = .41, p < .001). Using path analyses, we found that the associations between BPD features and pain severity and interference were accounted for by serial indirect pathways through affective lability then pain anxiety and, to a lesser extent, through trait anxiety then pain anxiety. This is the first study to demonstrate roles for affective lability and pain anxiety sensitivity in the association between BPD features and chronic pain complaints in a chronic pain sample. We discuss implications for the relationship between dysregulated emotion and pain as well as for psychologically-focused treatment interventions for pain. (PsycINFO Database Record (c) 2018 APA, all rights reserved).

Entities:  

Mesh:

Year:  2017        PMID: 28206807     DOI: 10.1037/per0000237

Source DB:  PubMed          Journal:  Personal Disord        ISSN: 1949-2723


  7 in total

1.  Exploring the links among borderline personality disorder symptoms, trauma, and pain in patients with chronic pain disorders.

Authors:  Benjamin N Johnson; Mark A Lumley; Jennifer S Cheavens; Lindsey C McKernan
Journal:  J Psychosom Res       Date:  2020-06-01       Impact factor: 3.006

2.  Momentary assessment of everyday physical pain in outpatients with borderline personality disorder.

Authors:  Ryan W Carpenter; Sarah L Tragesser; Sean P Lane; Timothy J Trull
Journal:  Personal Disord       Date:  2018-07-19

3.  Dialectical Pain Management: Feasibility of a Hybrid Third-Wave Cognitive Behavioral Therapy Approach for Adults Receiving Opioids for Chronic Pain.

Authors:  Deborah Barrett; Carrie E Brintz; Amanda M Zaski; Mark J Edlund
Journal:  Pain Med       Date:  2021-05-21       Impact factor: 3.750

Review 4.  Recent advances in understanding physical health problems in personality disorders.

Authors:  Katherine L Dixon-Gordon; Lindsey C Conkey; Diana J Whalen
Journal:  Curr Opin Psychol       Date:  2017-09-13

5.  Linking Daily-Life Interpersonal Stressors and Health Problems Via Affective Reactivity in Borderline Personality and Depressive Disorders.

Authors:  Johanna Hepp; Sean P Lane; Ryan W Carpenter; Timothy J Trull
Journal:  Psychosom Med       Date:  2020-01       Impact factor: 3.864

6.  Manifestation of Borderline Personality Symptomatology in Chronic Pain Patients Under Stress: An Understated and Exacerbated Consequence of the COVID-19 Crisis.

Authors:  Hannah Shapiro; Ronald J Kulich; Michael E Schatman
Journal:  J Pain Res       Date:  2020-06-15       Impact factor: 3.133

7.  Self-Reported Pain and Emotional Reactivity in Bipolar Disorder: A Prospective FACE-BD Study.

Authors:  Nathan Risch; Jonathan Dubois; Katia M'bailara; Irena Cussac; Bruno Etain; Raoul Belzeaux; Caroline Dubertret; Emmanuel Haffen; Raymund Schwan; Ludovic Samalin; Paul Roux; Mircea Polosan; Marion Leboyer; Philippe Courtet; Emilie Olié
Journal:  J Clin Med       Date:  2022-02-08       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.